Speaking of economic opportunity, and the general benefits of wide-ranging growth, President John Kennedy once said, “A rising tide lifts all boats.” As …
The stock market is heating up, and some Wall Street bulls are turning even more positive. Among those adapting an increasingly bullish approach …
It’s one small step forward for Vascular Biogenics (VBLT), one giant leap for the company’s stock rating. H.
Investors have been treated like rented mules by the market so far here in October. More than 75% of the S&P 500 (including …
H.C.
Small biotech stocks are often considered “binary” lottery-ticket type events, with either a small chance of big upside, or a much greater probability …
Shares of Vascular Biogenics Ltd (NASDAQ:VBLT) slumped on Friday, falling 18% as of 10:30 a.m.
Roth Capital analyst Joseph Pantginis weighed in with a few insights on Vascular Biogenics Ltd (NASDAQ:VBLT), after the Israeli biotech company presented updated data from its Phase …
Oppenheimer analyst Yigal Nochomovitz initiated an Outperform rating on Vascular Biogenics (NASDAQ:VBLT) with a $16 price target, which implies an upside of 144% from current levels. Nochomovitz …